Cullinan Therapeutics
Developing clinical-stage targeted therapies for oncology and autoimmune diseases.
Company facts
- Founded
- 2016
- Employees
- 111
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: CGEM
- Subsidiaries
- Cullinan Amber, Cullinan Florentine, Cullinan Mica, Cullinan Pearl, Cullinan Securities